Terumo Invests 26 Million Euro in New Production Lines for its Leuven Facility

08/07/2019

Terumo Corporation, a leading global medical device manufacturer, today announced an investment of 26 million euro in the production facility of Terumo Europe in Leuven (Belgium), where Terumo produces and assembles medical devices. Terumo extends its production capacity at Terumo Europe to meet the growing demand for Terumo products. The new production lines will be operational within two to three years. Terumo Europe employs approximately 1,300 people in the EMEA region.

At the site in Leuven, Terumo produces and assembles medical devices in two production entities.

'For the Alliance division, we will extend our capacity in moulding. We will increase the number of needle assembly lines and we are investing in a flexible assembly line that will allow us to customize production for our customers. For our Interventional Systems division, we will further automate production processes in assembly and packaging', said Henk Houf, Chief Operations Officer of Terumo Europe.

'We are excited that Terumo invests in the production site in Leuven. We believe this investment will accelerate the growth of these two divisions, which will drive the overall Terumo growth in mid- to long-term', said Nori Kunimoto, CEO Terumo Europe.


Source: Terumo